Tumor Mutation Services
-
Manufactured by Yashraj Biotechnology Ltdbased in INDIA
Yashraj Biotechnology Ltd.’s (YBL) offers Development of Primary Cell line(s), both from normal and tumor tissues. YBL offers Transformation of cell lines by introduction of external DNA that drives the Transformation process by sustaining proliferative signaling, evading growth suppressors, resisting cell death, enabling ...
-
based in FRANCE
Genetic cancer analyses are particularly challenging due to the huge number of de novo variants and the need to combine DNA and RNA data in some cases. This requires a unique set of interpretation tools and specifically tuned ...
-
Manufactured by Inovotion Sasbased in FRANCE
Target validation is an essential and critical phase of the drug discovery process. This is a crucial step before starting to develop a treatment based on a targeted protein that has been identified to play a role in the disease. The target protein’s role must be clearly identified before starting to develop a drug candidate against the disease and evaluate if the drug acts on the ...
-
based in USA
Tissue500™ is a comprehensive genomic profiling test that detects clinically relevant mutations in 572 genes to identify a patient’s unique cancer ...
-
based in USA
LiquidHALLMARK® is an ultrasensitive next-generation sequencing assay for genomic profiling of a patient’s unique cancer. By requiring only a single blood sample, LiquidHALLMARK provides important information for cancer care especially when tissue by invasive biopsy is insufficient or ...
-
Manufactured by Veracytebased in FRANCE
From our proprietary biomarkers, our innovated assays solutions, our unique data analysis platforms and our CDx development capabilities, we offer a comprehensive family of biomarker services that enhance your insight into the tumor microenvironment ...
-
Manufactured by IMB Dx, Inc.based in SOUTH KOREA
Analysis of cancer-related genes through blood. Through a simple blood draw, key genes related to various cancer types of solid cancers (including gastric, lung, colon, breast, liver, pancreatic, ovarian and uterine cancer, as well as rare cancers such as melanoma and sarcoma) can be tested for somatic ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you